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Abstract
Context
Low-grade appendiceal mucinous neoplasm (LAMN) and appendiceal adenocarcinoma are
known to cause the majority of pseudomyxoma peritonei (PMP, i.e. mucinous ascites); how-
ever, recognition and proper classification of these neoplasms can be difficult despite estab-
lished diagnostic criteria.
Objective
To determine the pathological diagnostic concordance for appendix neoplasia and related
lesions during patient referral to an academic medical center specialized in treating patients
with PMP.
Design
The anatomic pathology laboratory information system was searched to identify cases over
a two-year period containing appendix specimens with mucinous neoplasia evaluated by an
outside pathology group and by in-house slide review at a single large academic medical
center during patient referral.
Results
161 cases containing appendix specimens were identified over this period. Forty-six of 161
cases (28.6%) contained appendiceal primary neoplasia or lesions. Of these, the originating
pathologist diagnosed 23 cases (50%) as adenocarcinoma and 23 cases (50%) as LAMN;
however, the reference pathologist diagnosed 29 cases (63.0%) as LAMN, 13 cases
(28.3%) as adenocarcinoma, and 4 cases (8.7%) as ruptured simple mucocele. Importantly,
for cases in which the originating pathologist rendered a diagnosis of adenocarcinoma, the
reference pathologist rendered a diagnosis of adenocarcinoma (56.5%, 13 of 23), LAMN
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(39.1%, 9 of 23), or simple mucocele (4.3%, 1 of 23). The overall diagnostic concordance
rate for these major classifications was 71.7% (33 of 46) with an unweighted observed
kappa value of 0.48 (95% CI, 0.27–0.69), consistent with moderate interobserver agree-
ment. All of the observed discordance (28.3%) for major classifications could be attributed
to over-interpretation. In addition, the majority of LAMN cases (65.5%) had potential diag-
nostic deficiencies including over-interpretation as adenocarcinoma and lacking or discor-
dant risk stratification (i.e. documentation of extra-appendiceal neoplastic epithelium).
Conclusions
Appendiceal mucinous lesions remain a difficult area for appropriate pathological classifica-
tion with substantial discordance due to over-interpretation in this study. The findings high-
light the critical need for recognition and application of diagnostic criteria regarding these
tumors. Recently published consensus guidelines and a checklist provided herein may help
facilitate improvement of diagnostic concordance and thereby reduce over-interpretation
and potential overtreatment. Further studies are needed to determine the extent of this phe-
nomenon and its potential clinical impact.
Introduction
Mucinous appendiceal neoplasms that may give rise to pseudomyxoma peritonei (PMP)
remain a challenging tumor type for pathological classification despite their description dating
back to the 19th century when the term PMP was first used by Werth.[1] Mucinous appendi-
ceal neoplasms comprise a spectrum from low-grade appendiceal neoplasm (LAMN) to vari-
ous grades of invasive adenocarcinoma.[2]
PMP is clinically defined as mucinous or gelatinous ascites and peritoneal implants associ-
ated with the pathological finding of neoplastic mucin-producing cells in the peritoneal cavity.
[2,3] It is now understood that the vast majority of PMP arise from perforated mucinous neo-
plasms of the appendix, and represent their peritoneal extension, with a minority of cases
being due to mucinous adenocarcinomas arising from other sites.[4] Ovarian origin of PMP is
rare and generally associated with mucinous adenocarcinoma arising from mature cystic tera-
toma.[5,6] Most cases of PMP have low-grade histologic features (sometimes termed “low-
grade mucinous carcinoma peritonei” according to the World Health Organization (WHO)),
while close to one quarter of cases have high-grade histologic features (sometimes termed
“high-grade mucinous carcinoma peritonei” according to the WHO) with a corresponding
worse prognosis.[4] In addition, the presence of signet ring cells has emerged as an indepen-
dent negative prognostic factor, especially if tissue invasion is seen.[7,8]
Although appendiceal neoplasms are relatively uncommon and encountered in less than
1–2% of incidental appendectomies, mucinous neoplasms and well-differentiated neuroendo-
crine tumors, also known as “carcinoids”, comprise the majority. [9,10] In contrast to neopla-
sia, by far the most common appendiceal diagnosis in surgical pathology is acute appendicitis.
[11,12]
Several classification schemes have been published to help determine risk for recurrent dis-
ease in LAMN.[3,13–17] Studies have demonstrated that patients with LAMNs that are con-
fined to the appendix remain disease free upon follow up.[14,15,18,19] Additionally, the
presence of acellular mucin or neoplastic epithelium at the appendectomy margin of LAMNs
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confined to the appendix is not a predictor of peritoneal recurrence.[15,19] Moreover, a clear
link has been established between the presence of extra-appendiceal neoplastic epithelium and
risk for recurrent disease, wherein LAMNs lacking extra-appendiceal neoplastic epithelium
are considered to be at low risk of peritoneal recurrence and LAMNs with extra-appendiceal
neoplastic epithelium are at high risk of recurrence.[14,15,18,20]
Clinical management of LAMN with and without extra-appendiceal neoplastic epithelium
is controversial.[17,21] A diagnosis of LAMN with low risk of recurrence can thus be used
to justify conservative clinical follow-up, while at some centers LAMN with high risk of re-
currence has been used to justify the pursuit of more aggressive therapies such as right he-
micolectomy, cytoreductive surgery (CRS), with or without hyperthermic intraperitoneal
chemotherapy (HIPEC) upon identification of dissemination to the peritoneal surfaces.[18]
Other institutions have reported successful long-term outcomes with close observation of
select patients with LAMN with high risk of recurrence, including some patients with limited
peritoneal dissemination.[22] Our institution has adopted an individualized approach that, in
general, includes close observation of patients with LAMN with low or high risk of recurrence,
in the absence of peritoneal dissemination.
Because proper histologic classification can strongly influence both prognosis and treat-
ment,[23] we performed a retrospective pathological chart review to measure the actual con-
cordance rate between community pathologists and a single large academic medical center
during patient referral.
Materials and methods
Human research protections program
This study was approved by the Institutional Review Board Human Research Protections Pro-
gram at the University of California San Diego (UCSD). Informed consent was not required
for this study.
Identification of appendix cases
Retrospective chart review was performed for a 2-year period (2014–2015) and included
pathology records obtained from the anatomic pathology laboratory information system (AP
LIS) and the general electronic medical record. The AP LIS was searched to identify pathology
cases containing appendix resection specimens (i.e. appendectomies, right hemicolectomies,
etc.) with mucinous neoplasia evaluated both by an outside pathology group and by in-house
slide review at UCSD during patient referral. Cases were included if there was a primary
appendiceal neoplasm or lesion, and excluded if incidental or contained secondary neoplasia
or other unrelated pathology. In addition, pathology records had to be readily available at the
time of chart review.
Pathologic evaluation and concordance
A retrospective chart review of original pathology reports was performed for all cases. Prospec-
tive pathological evaluation at the reference institution, a single large academic medical center
(UCSD), was performed solely by a subspecialized GI pathology clinical service via protocol
in-house slide review during patient referral for oncologic care. None of the cases were second-
ary consultations specifically requested by the original evaluating pathologist. Reference
pathologists were not provided with prior study specific training sets. The histopathological
slides were reviewed prospectively in 91% of the overall cases by at least one fellowship-trained
GI pathologist and 74% by a GI pathologist with special interest in appendiceal neoplasia
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(MV). All cases having disagreement with the originating pathologist were evaluated prospec-
tively by the lead study pathologist (MV) and shown to more than one reference pathologist.
In general, such cases are returned to the originating institution after a short grace period;
therefore, a comprehensive retrospective histopathological review was not performed. Exam-
ple microscopic images from selected available cases are provided for illustration.
Concordance was measured as the total number of cases placed in the same diagnostic
category (LAMN, adenocarcinoma, mucocele) by both the initial pathologist report and the
second evaluation report. Cases were placed in the adenocarcinoma category if the term “ade-
nocarcinoma” was included in the final pathological diagnosis. For cases without adenocarci-
noma in the final pathological diagnosis, utilization of the term LAMN or other borderline
malignant terminology such as “uncertain malignant potential” was placed the case in the
LAMN category. “High-risk” LAMN refers to the presence of extra-appendiceal neoplastic epi-
thelium which confers a high-risk of disease recurrence in the peritoneum, whereas “low-risk”
LAMN here refers to the lack of extra-appendiceal neoplastic epithelium and includes cases
with only extra-appendiceal acellular mucin and also cases thought to be entirely confined
to the appendix [15]. Cases in which the location of the neoplastic epithelium could not be
definitively determined were categorized as ambiguous, and cases lacking documentation of
the presence or absence of extra-appendiceal neoplastic epithelium on the original pathology
report were noted. In addition, mucocele as used herein refers to a non-neoplastic simple mu-
cocele (sometimes also called a “mucous retention cyst”). Definitions of over-interpretation
and under-interpretation are utilized as described previously [24]. Briefly, over-interpretation
is defined as reporting a diagnosis of a higher category of malignancy than the reference;
whereas, under-interpretation is defined as reporting a diagnosis of a lower category of malig-
nancy than the reference. Unweighted Kappa values to determine interobserver agreement
were calculated according to Fleiss and Cohen.[25]
Results
Overall case and originating practice characteristics
161 cases were identified that included appendix specimens over the period of study. Forty-
six of 161 cases (28.6%) contained appendiceal primary neoplasia or lesions. Of the 46 initial
diagnostic case surgical specimens, 35 (76.1%) were appendectomies, 6 (13.0%) were right
hemicolectomies, 2 (4.3%) were appendectomies with partial cecectomy, 1 (2.2%) was an ileo-
cecectomy, 1 (2.2%) was an appendectomy with cecectomy and pelvis mass excision, and 1
(2.2%) was an appendectomy with hysterectomy, bilateral salpingo-oopherectomy, splenec-
tomy, and omentectomy. The 115 excluded cases had a wide variety of diagnoses including
incidental appendectomies, secondary involvement by other neoplasms including mesotheli-
oma, leiomyosarcoma, serous ovarian carcinoma, and other diagnoses unrelated to primary
appendiceal disease. No cases were excluded due to lack of availability of pathology records.
Patients referred for primary appendiceal neoplasia ranged in age from 29 to 81 years old with
an average of 55 years old (median 59 years old) and patients were more likely to be female
(M:F ratio 1:1.56). The in-house slide review was generally requested by an attending surgical
oncologist during patient referral for oncologic care. The originating pathologist practices
were usually mid-sized (number of pathologists, average 10, median 7) and non-academic
(91.3%) with moderate surgical case volumes (average 22,000 accessions per annum, median
18,000 accessions per annum). The primary signing pathologist was usually not subspecialized
in gastrointestinal pathology (87%) and consulted another pathologist(s) in a large fraction of
the cases (37%).
Appendix cancer overinterpretation
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Pathological evaluations and diagnostic concordance
The distribution of appendiceal diagnoses from the originating pathologist was 50% adenocar-
cinoma (23 of 46), 50% LAMN (23 of 46), and 0% mucocele (0 of 46, Fig 1). In contrast, the
distribution of appendiceal diagnoses from the reference academic pathologist was 28.3% ade-
nocarcinoma (13 0f 46), 63% LAMN (29 of 46), and 8.7% mucocele (4 of 46). Subclassification
demonstrated that the adenocarcinomas were 30.8% (4 of 13) adenocarcinoma ex goblet cell
carcinoid, 23.1% (3 of 13) adenocarcinomas arising from low-grade appendiceal mucinous
neoplasm (LAMN), and 46.2% (6 of 13) mucinous adenocarcinomas not otherwise specified.
LAMNs were predominantly high-risk with extra-appendical neoplastic epithelium (62.1%, 18
of 29), low-risk without extra-appendiceal neoplastic epithelium (24.1%, 7 of 29), or not speci-
fied or ambiguous (13.8%, 4 of 29).
For cases in which the originating pathologist rendered a diagnosis of adenocarcinoma, the
reference pathologist rendered a diagnosis of adenocarcinoma (56.5%, 13 of 23), LAMN
(39.1%, 9 of 23), or simple mucocele (4.3%, 1 of 23). For cases in which the originating pathol-
ogist rendered a diagnosis of LAMN, the reference pathologist rendered a diagnosis of LAMN
(87.0%, 20 of 23) or simple mucocele (13.0%, 3 of 23). Conversely, when the reference patholo-
gist rendered a diagnosis of adenocarcinoma, the originating pathologist was universally in
agreement (100%, 13 of 13). When the reference pathologist rendered a diagnosis of LAMN,
the originating pathologist rendered a diagnosis of adenocarcinoma (31.0%, 9 of 29) or LAMN
(69.0%, 20 of 29). When the reference pathologist rendered a diagnosis of simple mucocele
(non-neoplastic), the originating pathologist rendered a diagnosis of adenocarcinoma (25%, 1
of 4) or LAMN (75%, 3 of 4, Figs 2 and 3).
The differences in distributions of major diagnostic categories resulted in an overall con-
cordance rate of 71.7% (33 of 46, Fig 1). When utilizing the secondary academic pathologist
evaluation as the reference evaluation, the originating pathologists diagnosed invasive adeno-
carcinoma with a concordance rate of 100% (13 of 13), whereas LAMN was diagnosed with a
concordance rate of 69% (20 of 29), and mucocele was diagnosed with a concordance rate of
Fig 1. Concordance for major diagnostic categories of appendiceal lesions. Greyed boxes indicate
concordant diagnoses between the originating pathologist and academic pathologist. AdCA indicates
adenocarcinoma; LAMN, low-grade appendiceal mucinous neoplasm.
https://doi.org/10.1371/journal.pone.0179216.g001
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0% (0 of 4). The overall unweighted kappa value was 0.48 (95% CI, 0.27–0.69) consistent with
moderate interobserver agreement. It should be noted that in no case were there disagree-
ments in interpretation due to under-interpretation by the originating pathologist. Therefore,
all of the discordance (28.3%, 13 of 46 cases) can be attributed to over-interpretation by the
originating pathologist when compared to the secondary reference pathologist.
Diagnostic challenges for LAMN
Of the 29 LAMN cases as diagnosed by the reference pathology group, nine were originally
diagnosed as adenocarcinoma (31.0%, 9 of 29). Additional potential diagnostic deficiencies
were identified including discordant documentation of features needed for risk stratification
(6.9%, 2 of 29) in which both such cases were documented as confined to the appendix at the
originating pathology practice; whereas, the reference pathologist believed there to be extra-
appendiceal neoplastic epithelium (i.e. high risk of recurrence). Several cases (31.0%, 9 of 29)
lacked documentation of extra-appendiceal neoplastic epithelium by histological description,
risk stratification (i.e. “high risk of recurrence” or “low risk of recurrence”), or TNM staging in
the original pathology report; however, one of these cases (1 of 9) could not be categorized by
the reference pathologist. Two LAMN cases (6.9%, 2 of 29) used non-standard terminology,
namely “mucinous cystic neoplasm of uncertain malignant potential” and “appendiceal mu-
cinous neoplasm with focal high-grade dysplasia” according to consensus guidelines which
would advocate the use of LAMN and high-grade appendiceal mucinous neoplasm (HAMN),
respectively.[3] It should be noted that advocacy for the use of HAMN for primary intralum-
inal appendiceal mucinous neoplasm that mimics LAMN but has high-grade cytologic features
Fig 2. Examples of discordant simple non-neoplastic mucocele cases. A and B, Appendiceal cross sections with concentric mucosal atrophy and
architectural changes of the crypts. C, While decreased, the crypts are focally present within the lamina propria and no cytologic atypia is seen. D,
Appendiceal cross section with crypt architectural changes indicating prior mucosal damage. E and F, Appendiceal tip with architectural changes and
evidence of prior rupture, including transmural fibrosis and extra-appendiceal mucin. (hematoxylin& eosin, original magnifications x20 [A], x40x [B], 200x
[C], 40x [D], 20x [E], and 40x [F]).
https://doi.org/10.1371/journal.pone.0179216.g002
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was strong, but not universal in the consensus statement (68%, 30 of 44).[3] Importantly, nei-
ther of these two cases had documentation of the presence or absence of extra-appendiceal
neoplastic epithelium. Therefore, a total of 19 of 29 LAMN cases (65.5%) had potential diag-
nostic deficiencies when compared to the reference pathology evaluation.
Discussion
Discordance in primary appendiceal lesions
This study demonstrates that the overall concordance rate in primary appendiceal mucinous
neoplasia is 71.7% (kappa 0.48) consistent with moderate interobserver agreement as seen in
recent normative community to academic patient referral practice. Interestingly, the discor-
dance for appendiceal neoplasia (28.3%) is quite similar to that seen when breast biopsy
Fig 3. Examples of low-grade appendiceal mucinous neoplasms (LAMN) and adenocarcinoma. A, Appendiceal base with LAMN and acellular
mucin. B, Cytologic atypia seen in LAMN with subjacent abnormal fibrotic stroma without intact lamina propria. C, Florid case of LAMN. D, Cytologic atypia
seen in LAMN with undulating and flat profiles and abnormal underlying stroma. E, Invasive adenocarcinoma arising from LAMN and penetrating smooth
muscle of the muscularis propria. F, Invasive mucinous adenocarcinoma arising from LAMN with invasion of the smooth muscle layers seen in the bottom
left portion of the micrograph. G, LAMN. H, LAMN with abnormal stroma lacking an intact lamina propria. I, Peritoneal extension of LAMN which resembles
the luminal neoplasm and includes a hyalinized stroma. (hematoxylin& eosin, original magnifications x40 [A], x200 [B], x40 [C], x200 [D], x400 [E], x400 [F],
x200 [G], x200 [H], and x200 [I]).
https://doi.org/10.1371/journal.pone.0179216.g003
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diagnoses were compared among pathologists (24.7%) [24]. When utilizing the secondary aca-
demic pathologist evaluation as the reference evaluation, the originating pathologists diag-
nosed invasive adenocarcinoma with a concordance rate of 100% (13 of 13), whereas LAMN
was diagnosed with a concordance rate of 69% (20 of 29), and mucocele was diagnosed with a
concordance rate of 0% (0 of 4). These latter findings may be due in part to a referral bias in
which patients with malignant but not benign diagnoses as dictated by the originating pathol-
ogy report are referred to an academic center for oncologic care, thus selecting for cases with
malignant diagnoses. Therefore, our study is likely to be a sensitive test for over-interpretation
in the community. Indeed, 31% of LAMNs (9 of 29) and 100% of mucoceles (4 of 4) in this
study were over-interpreted by the originating pathologist, and over-interpretation accounted
for 100% of the overall major category discordance. It should be noted that 2 cases of LAMNs
had discordant risk stratification in which the originating pathologist rendered a low-risk cate-
gorization, and the secondary reference pathologist rendered a high-risk categorization; there-
fore, at this hierarchical level under-interpretation was identified. If this distinction were
included in the overall concordance, the rate would be 67.4%, rather than 71.7%. LAMN cases
lacking risk stratification (i.e. documentation of extra-appendiceal neoplastic epithelium) were
considered potential diagnostic deficiencies rather than a specific diagnostic category, but
appear to be an important source of reporting differences as the reference pathologist could
resolve 88.9% (8 of 9) of LAMN cases initially lacking risk stratification. Equal numbers of
adenocarcinoma and LAMN (as diagnosed by the originating pathologist) were referred for
care, and since either diagnosis can be sufficient for referral, the referral bias may be limited,
although the percentage of cases referred from each of those two categories is unknown and
could differ. It is nevertheless possible that the current study may underestimate the actual rate
of under-interpretation in the community; therefore, the actual overall diagnostic discordance
for appendiceal lesions at large may also be underestimated.
The concordance rates in this study are compared to normative practice in a large academic
referral center for appendiceal neoplasms. Neither specific training nor test sets were given
to the originating or secondary pathologists to improve conformity to consensus guidelines.
Common practice at our institution is in accord with current diagnostic standards and is
compatible with recently published guidelines by the Peritoneal Surface Oncology Group
International and the World Health Organization.[2,3] Therefore, the findings measure actual
diagnostic concordance in referral practice, but may also be a reasonable approximation of dis-
cordance with current diagnostic standards.
Although the total number of LAMNs and mucoceles in the catchment community is
unknown, the presence of multiple over-interpreted cases as identified in this study suggests
the possibility of a relatively common systematic error occurring in the routine pathological
evaluation of such cases. We found no clear patterns with respect to non-academic versus aca-
demic practices, practice size, or gastrointestinal subspecialization; however, it should be
noted that additional larger studies are needed to better understand these and other parame-
ters involved in the process of rendering complex pathological diagnoses in general, and
LAMNs and related mucinous lesions in particular. Our findings do suggest an awareness of
the difficulty of appendiceal mucinous neoplasia cases given that 37% of the cases (17 of 46)
were shown to another pathologist at the originating practice, as compared to common peer
case review rates for general quality control and assurance measures according to our experi-
ence and others that are usually10% [26].
We speculate that misdiagnosis occurs, at least in part, due to apparent misconceptions
regarding these lesions including the incorrect concepts that mucoceles are always neoplastic
and that LAMNs are equivalent to adenocarcinomas. In addition, there appears to be confu-
sion regarding the significance of extra-appendiceal neoplastic cells (confers high risk of
Appendix cancer overinterpretation
PLOS ONE | https://doi.org/10.1371/journal.pone.0179216 June 7, 2017 8 / 14
recurrence). Acellular mucin must be carefully scrutinized in every section in which it occurs
and the appendix specimen must be entirely submitted to exclude the presence of extra-appen-
diceal neoplasm. Rarely, degenerating extra-appendiceal mucinous epithelial cells can mimic
histiocytes or mesothelial cells, thereby necessitating immunohistochemical evaluation for
clarification (i.e. CDX2 for staining mucinous intestinal-type epithelium, CD68 for histiocytes,
and calretinin, WT-1 or other markers for mesothelial cells).
Diagnosis of primary appendiceal lesions
To further highlight diagnostic criteria and to aid in proper categorization of appendiceal neo-
plasia cases, we have included a checklist in Table 1. Regardless of the absence or presence of
acute appendicitis, any abnormal appearing appendix with a dilated lumen, excessive mucin,
or abnormal appearing epithelium or mucosa (i.e. cytological atypia, architectural changes,
mucosal atrophy, etc.), should be evaluated more closely and submitted entirely for histological
evaluation to exclude the presence of luminal neoplastic/dysplastic epithelium. If there is no
Table 1. Proposed checklist for appendiceal neoplasia.
Appendix Entirely Submitted
___ Yes, entirely submitted
___ No, representative sections only
___ Unknown
Definitive Luminal Neoplastic Epithelium
___ Present
___ Not identified
___ Cannot be determined
Loss of Lamina Propria/Muscularis Propria and Stromal Hyalinization
___ Present
___ Not identified
___ Cannot be determined
Extra-appendiceal Mucin
___ Present
___ Not identified
___ Cannot be determined
Extra-appendiceal Neoplastic Epithelium*
___ Present
___ Not identified
___ Cannot be determined
Destructive or Infiltrative Invasion/Tumor Budding**
___ Present
___ Not identified
___ Cannot be determined
Surgical Evaluation for Peritoneal Disease
___ Yes, peritoneal disease present
___ Yes, peritoneal disease absent
___ Evaluation not performed or incomplete
___ Unknown
* If present, confers high risk of recurrence in LAMN
** Small, irregular glands in a desmoplastic stroma and/or discohesive single cells or clusters of up to 5
cells; if present, diagnostic of adenocarcinoma
https://doi.org/10.1371/journal.pone.0179216.t001
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luminal neoplastic/dysplastic epithelium after comprehensive histological evaluation, then the
appendix is reactive or hyperplastic, represents a simple non-neoplastic mucocele (i.e. reten-
tion cyst), or may harbor a serrated polyp (this category includes hyperplastic polyps and ses-
sile serrated adenomas). If definitive luminal neoplastic/dysplastic epithelium is present, then
identification of destructive invasion is critical for determining whether there is invasive ade-
nocarcinoma [2,15]. Features of destructive or infiltrative invasion have been most recently
defined specifically as including tumor budding (discohesive single cells or clusters of up to 5
cells) and/or small, irregular glands typically within a desmoplastic stroma characterized by a
proteoglycan-rich extracellular matrix with activated fibroblasts/myofibroblasts with vesicular
nuclei.[3] Once invasive adenocarcinoma has been established, then subclassifying as well-,
moderately-, or poorly-differentiated is straightforward and similar to other sites in the gastro-
intestinal tract; adenocarcinomas with <50% mucin (or signet ring cells) should be diagnosed
as adenocarcinoma with mucinous (or signet ring cell) features; whereas, adenocarcinomas
with>50% mucin (or signet ring cells) should be diagnosed as mucinous (or signet ring cell)
adenocarcinoma.[2] Rarely, appendiceal endometriosis involved by intestinal metaplasia can
occur and mimic adenocarcinoma.[27,28]
Another key problem area is differentiating neoplastic/dysplastic lesions that lack overt
destructive invasion. These lesions include adenomas of various sorts that mimic their colorec-
tal counterparts (i.e. tubular adenoma, tubulovillous adenoma, traditional serrated adenoma,
sessile serrated adenoma with conventional/cytological dysplasia) and LAMN. The key dis-
criminator between these entities is the presence of so-called pushing invasion present in
LAMNs which manifests itself as obliteration of the lamina propria and/or muscularis muco-
sae (may have loss of the normal mucosa associated lymphoid tissue) and fibrosis and hyalini-
zation of the underlying stroma (generally submucosa or deeper levels of the appendiceal
wall). There can also be associated luminal dilatation, diverticula, and sometimes perforation
and rupture of the appendix, although these features are not specific to LAMN and can be seen
in non-neoplastic retention cysts. In contrast, colorectal adenomas exhibit expected architec-
ture as seen in the colon and rectum, and have intact lamina propria and muscularis mucosae,
except in cases in which the neoplasm has already progressed to a frankly invasive adenocarci-
noma. Serrated polyps of the appendix have serrated luminal profiles often with basal dilata-
tion as can be seen in sessile serrated adenomas of the colon and rectum. In general, these lack
overt cytological (also called conventional) dysplasia. Cases of serrated polyp with extensive
cytological dysplasia may be difficult to distinguish, but should have serrated profiles and
intact lamina propria and muscularis mucosae. Moreover, serrated polyp may occasionally
have mutated BRAF which is detectable by molecular or immunohistochemical methods.
[29,30] Other conventional adenomas of the appendix should be similar to their colorectal
counterparts, and lack pushing invasion having an intact lamina propria and muscularis
mucosae. In villform lesions, care should be taken to evaluate the basal architecture and stroma
to determine whether or not LAMN is a diagnostic possibility. One study suggests combining
conventional adenomas and LAMN into a single diagnostic category in part because of their
high rates of KRAS and low rates of BRAF mutation; however, their capacity for peritoneal dis-
semination differs. [29]
Once a diagnosis of LAMN has been made, then determination of the extent of the neo-
plasm is critical–specifically whether there is extra-appendiceal neoplastic epithelium. To fully
exclude the presence of extra-appendiceal neoplastic epithelium, the entire appendix must be
submitted for histologic evaluation. The extra-appendiceal neoplastic epithelium can closely
line the peritoneal surface or can be organized as strips and islands of bland-appearing neo-
plastic epithelium floating in large pools of mucin outside the wall. Difficulty arises in areas of
perforation without clearly externalized neoplastic epithelium, because rupture or perforation
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itself is a necessary, but not a sufficient, event to confer a high-risk of recurrence.[15] In these
rare cases, confident documentation of the presence or absence of extra-appendiceal neoplastic
epithelium may not be possible on histological assessment, and therefore close clinical follow-
up would be warranted. Indeed, in the current study one such case was encountered (3.4%, 1
of 29 LAMN cases) in which neither the originating or secondary pathologist determined a
risk of recurrence. In contrast to extra-appendiceal neoplastic cells, extra-appendiceal acellular
mucin does not confer high risk, but should be cause for carefully scrutinizing the specimen
for the presence of extra-appendiceal neoplastic cells. If a LAMN is completely confined by the
appendix (i.e. only present within the appendiceal lumen without evidence of perforation or
extra-appendiceal mucin after complete histological evaluation) and there is no gross evidence
of peritoneal disease at the time of surgery, then there is a negligible risk of recurrence as previ-
ously published studies indicate that such patients remain disease free upon follow up (0%
recurrence, 0/75 patients).[14,15,18,19] Nevertheless, clinical follow-up may be warranted in
certain patients, and additional larger studies are needed to help further establish the precise
risk of recurrence in this specific scenario.
Appendiceal mucocele is a descriptive macroscopic or gross term used for a dilated appen-
dix filled with mucin. In our opinion, despite continued usage, appendiceal mucocele should
not be used to connote neoplasia. In this study, the term simple mucocele has been used to
refer to a non-neoplastic “mucous retention cyst”. It has been observed that these non-neo-
plastic mucoceles generally have a small diameter and rarely exceed 1.5–2.0 cm in diameter;
whereas, the vast majority of cases with larger diameters are indeed neoplastic.[13,31] On his-
tology, simple mucoceles lack ctyologic atypia and neoplastic epithelium, and have at least par-
tially intact lamina propria including crypt profiles.
Staging of appendiceal neoplasia
A diagnosis of adenocarcinoma requires evidence of destructive tissue invasion in the form of
irregular glands with desmoplasia, or overtly invasive individual cells (including signet ring
cells).[15] Despite LAMN lacking destructive tissue invasion and having a much better prog-
nosis as compared to conventional invasive adenocarcinoma, they have been placed in the ade-
nocarcinoma category by both the WHO and the American Joint Committee on Cancer
(AJCC) in 2010.[2,32] The WHO acknowledges LAMN as a distinct nosological entity separate
from mucinous adenocarcinoma and signet ring cell carcinoma; however, the AJCC accom-
modates differences in outcomes only by distinguishing mucinous versus non-mucinous
adenocarcinomas.[2,32] The limitations of these classification systems becomes clear when
considering an truly invasive adenocarcinoma that arises from precursor LAMN. Indeed,
23.1% of the invasive adenocarcinoma cases in this series arose from a background of LAMN.
Another confounder is that LAMN can have quite extensive surface disease (without invasion)
of the peritoneum, involve the ovaries, uterus, and even the endometrial surface presumably
via fallopian tube transit.[33,34] Despite this, at our institutions, we currently continue to
utilize both carcinoma pathological staging (TNM, as per AJCC) and “risk stratification” to
emphasize the extent of tumor and to aid in determination of appropriate clinical follow up;
however, it should be reiterated that the presence or absence of extra-appendiceal should
always be documented in some manner in cases of LAMN.[15,16,32]
Conclusions
LAMN and their peritoneal dissemination remain a difficult area for appropriate pathological
classification. This study demonstrates a moderate diagnostic agreement for the diagnosis of
primary appendiceal mucinous neoplasia in normative pathology and patient referral practice.
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Published consensus guidelines may facilitate clarification of classification and improvement
of diagnostic concordance; however, clarified algorithmic diagnostic approaches based closely
on the anatomy and biological potential of these neoplasms are needed. Because of the inher-
ent difficulties of these cases, many with borderline malignant potential and disrupted anat-
omy, we recommend consideration of expert secondary pathological review at large academic
referral centers that frequently encounter these lesions. Further studies are needed to help clar-
ify clinical outcomes and improve current diagnostic evaluation in part by incorporating
emerging biomarkers will the goal of providing improved prognostic and therapeutic informa-
tion for patient care regarding this disease.
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